KR102268976B1 - Antibacterial Nonwoven Dressing - Google Patents
Antibacterial Nonwoven Dressing Download PDFInfo
- Publication number
- KR102268976B1 KR102268976B1 KR1020190105412A KR20190105412A KR102268976B1 KR 102268976 B1 KR102268976 B1 KR 102268976B1 KR 1020190105412 A KR1020190105412 A KR 1020190105412A KR 20190105412 A KR20190105412 A KR 20190105412A KR 102268976 B1 KR102268976 B1 KR 102268976B1
- Authority
- KR
- South Korea
- Prior art keywords
- poly
- dressing
- resin
- antibacterial
- polyurethane
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 28
- 229920005989 resin Polymers 0.000 claims abstract description 27
- 239000011347 resin Substances 0.000 claims abstract description 27
- 239000002082 metal nanoparticle Substances 0.000 claims abstract description 13
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical group C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002250 absorbent Substances 0.000 claims abstract description 11
- 230000002745 absorbent Effects 0.000 claims abstract description 11
- -1 polyoxymethylene Polymers 0.000 claims description 51
- 239000002052 molecular layer Substances 0.000 claims description 19
- 239000004814 polyurethane Substances 0.000 claims description 17
- 239000011148 porous material Substances 0.000 claims description 16
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 15
- 238000001523 electrospinning Methods 0.000 claims description 15
- 239000002952 polymeric resin Substances 0.000 claims description 15
- 239000002121 nanofiber Substances 0.000 claims description 14
- 229920002530 polyetherether ketone Polymers 0.000 claims description 13
- 229920006324 polyoxymethylene Polymers 0.000 claims description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 12
- 239000004952 Polyamide Substances 0.000 claims description 12
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 12
- 239000004734 Polyphenylene sulfide Substances 0.000 claims description 12
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 12
- 229920002647 polyamide Polymers 0.000 claims description 12
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 12
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 12
- 229920000069 polyphenylene sulfide Polymers 0.000 claims description 12
- 229920002635 polyurethane Polymers 0.000 claims description 12
- 229920001410 Microfiber Polymers 0.000 claims description 11
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 11
- 239000004698 Polyethylene Substances 0.000 claims description 11
- 229920000573 polyethylene Polymers 0.000 claims description 11
- 239000004800 polyvinyl chloride Substances 0.000 claims description 11
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000004743 Polypropylene Substances 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 10
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 claims description 10
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 claims description 10
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 claims description 10
- 229920001707 polybutylene terephthalate Polymers 0.000 claims description 10
- 229920006380 polyphenylene oxide Polymers 0.000 claims description 10
- 229920001155 polypropylene Polymers 0.000 claims description 10
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 10
- 235000018102 proteins Nutrition 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 229910052709 silver Inorganic materials 0.000 claims description 10
- 239000004332 silver Substances 0.000 claims description 10
- 229920006305 unsaturated polyester Polymers 0.000 claims description 10
- 229920000805 Polyaspartic acid Polymers 0.000 claims description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 9
- 229920002101 Chitin Polymers 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 8
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 7
- 108010035532 Collagen Proteins 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 229920000954 Polyglycolide Polymers 0.000 claims description 7
- 229920000249 biocompatible polymer Polymers 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920001436 collagen Polymers 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 229920005615 natural polymer Polymers 0.000 claims description 7
- 239000004417 polycarbonate Substances 0.000 claims description 7
- 229920000515 polycarbonate Polymers 0.000 claims description 7
- 229920003002 synthetic resin Polymers 0.000 claims description 7
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052737 gold Inorganic materials 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 6
- 229910052763 palladium Inorganic materials 0.000 claims description 6
- 229910052697 platinum Inorganic materials 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
- 239000004593 Epoxy Substances 0.000 claims description 5
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 5
- 229910045601 alloy Inorganic materials 0.000 claims description 5
- 239000000956 alloy Substances 0.000 claims description 5
- 150000001408 amides Chemical class 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 239000011737 fluorine Substances 0.000 claims description 5
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 150000001299 aldehydes Chemical class 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 239000002105 nanoparticle Substances 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 2
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 2
- 239000004633 polyglycolic acid Substances 0.000 claims description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims 1
- 239000004626 polylactic acid Substances 0.000 claims 1
- 239000004926 polymethyl methacrylate Substances 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 23
- 229920000049 Carbon (fiber) Polymers 0.000 abstract description 11
- 206010052428 Wound Diseases 0.000 description 22
- 208000027418 Wounds and injury Diseases 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 12
- 239000000835 fiber Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 230000035699 permeability Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 8
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 7
- 238000009987 spinning Methods 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 6
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000004745 nonwoven fabric Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000000416 exudates and transudate Anatomy 0.000 description 4
- 239000012948 isocyanate Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000004332 deodorization Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- 239000005058 Isophorone diisocyanate Substances 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 239000002313 adhesive film Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 238000005253 cladding Methods 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000003658 microfiber Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920005749 polyurethane resin Polymers 0.000 description 2
- 229920005604 random copolymer Polymers 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- VGHSXKTVMPXHNG-UHFFFAOYSA-N 1,3-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC(N=C=O)=C1 VGHSXKTVMPXHNG-UHFFFAOYSA-N 0.000 description 1
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- VZXPHDGHQXLXJC-UHFFFAOYSA-N 1,6-diisocyanato-5,6-dimethylheptane Chemical compound O=C=NC(C)(C)C(C)CCCCN=C=O VZXPHDGHQXLXJC-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000004970 Chain extender Substances 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 244000062175 Fittonia argyroneura Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 1
- GWGWXYUPRTXVSY-UHFFFAOYSA-N N=C=O.N=C=O.CC1=CC=C(C)C=C1 Chemical compound N=C=O.N=C=O.CC1=CC=C(C)C=C1 GWGWXYUPRTXVSY-UHFFFAOYSA-N 0.000 description 1
- UQBRAHLFLCMLBA-UHFFFAOYSA-N N=C=O.N=C=O.CC1=CC=CC(C)=C1 Chemical compound N=C=O.N=C=O.CC1=CC=CC(C)=C1 UQBRAHLFLCMLBA-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- RRKGBEPNZRCDAP-UHFFFAOYSA-N [C].[Ag] Chemical compound [C].[Ag] RRKGBEPNZRCDAP-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- AYLRODJJLADBOB-QMMMGPOBSA-N methyl (2s)-2,6-diisocyanatohexanoate Chemical compound COC(=O)[C@@H](N=C=O)CCCCN=C=O AYLRODJJLADBOB-QMMMGPOBSA-N 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000909 polytetrahydrofuran Polymers 0.000 description 1
- 229920002620 polyvinyl fluoride Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00004—Non-adhesive dressings
- A61F13/00008—Non-adhesive dressings characterized by the material
- A61F13/00017—Non-adhesive dressings characterized by the material synthetic, e.g. polymer based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00004—Non-adhesive dressings
- A61F13/00021—Non-adhesive dressings characterized by the structure of the dressing
- A61F13/00029—Non-adhesive dressings characterized by the structure of the dressing made of multiple layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00004—Non-adhesive dressings
- A61F13/00034—Non-adhesive dressings characterized by a property
- A61F13/00042—Absorbency
-
- A61F13/01017—
-
- A61F13/01029—
-
- A61F13/01042—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/407—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties containing absorbing substances, e.g. activated carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00238—Wound bandages characterised by way of knitting or weaving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/02—Bandages, dressings or absorbent pads
- D10B2509/022—Wound dressings
Abstract
본 발명은 활성탄소섬유 및 상기 활성탄소섬유 사이 공간 일부에 수지가 결합되고, 상기 수지의 내부 및 표면에 금속나노 입자가 결합된 흡수층으로 구성된 항균 부직포 드레싱에 관한 것이다. The present invention relates to an antibacterial nonwoven dressing consisting of an absorbent layer in which a resin is bonded to an activated carbon fiber and a portion of the space between the activated carbon fibers, and metal nanoparticles are bonded to the inside and surface of the resin.
Description
본 발명은 항균 부직포 드레싱에 관한 것으로 보다 자세하게는 활성탄소섬유 사이 공간 일부에 금속나노 입자가 포함된 수지가 특징인 흡수층 및 그 양면에 나노층이 적층된 항균 부직포 드레싱에 관한 것이다.The present invention relates to an antibacterial nonwoven dressing, and more particularly, to an absorbent layer characterized by a resin containing metal nanoparticles in a portion of the space between activated carbon fibers, and an antibacterial nonwoven dressing in which nanolayers are laminated on both sides.
과거에는, 항균 약물을 신체의 상처부분에 직접 적용하였다. 최근에는, 상처의 유형에 따라, 의료용 테이프, 패치, 젤라틴 필름 붕대 및 드레싱과 같은 의료용 창상피복재를 상처를 감싸는데 사용한다. 그 결과, 상처는 외부 환경과의 부적절한 접촉으로부터 차단 및 보호됨으로써 감염을 방지하고 통증을 줄인다.In the past, antibacterial drugs were applied directly to wounds on the body. Recently, depending on the type of wound, medical wound dressings such as medical tapes, patches, gelatin film bandages and dressings are used to cover the wound. As a result, the wound is blocked and protected from inappropriate contact with the external environment, thereby preventing infection and reducing pain.
일반적으로 상처 치료용 드레싱은 상처 부위를 감싸주어 단백질의 손실을 감소시키고 상처 표면으로부터 열의 증발과 수분의 손실을 감소시키고 피부의 상처를 통풍시키게 하는 기능과 외부환경으로부터 상처의 오염을 방지하는 등 외과적으로 중요한 기능을 하고 있다. 또한 출혈에 의하여 혈장이 급격히 손실되는 경우에는 출혈이나 혈장의 손실을 최소화하는 역할도 한다.In general, dressings for wound treatment reduce the loss of protein by encapsulating the wound area, reduce the evaporation of heat and loss of moisture from the wound surface, ventilate the skin wound, and prevent contamination of the wound from the external environment. plays an important role. In addition, when plasma is rapidly lost due to bleeding, it also serves to minimize bleeding or loss of plasma.
그런데, 종래의 드레싱은 고압 멸균기로 살균하여 균을 죽이는 방법 외에 자체적인 항균 능력이 없었다.However, the conventional dressing did not have its own antibacterial ability other than the method of killing bacteria by sterilizing with a high-pressure sterilizer.
따라서, 상처 부위에서 세균이 완전히 살균되지 않은 상태로 드레싱을 하거나 외부로부터 세균이나 오염물질이 침투하거나, 드레싱 자체가 세균에 오염된 경우에 세균 감염에 무방비 상태가 되는 문제가 있었다.Therefore, there is a problem in that the dressing is not completely sterilized at the wound site, when bacteria or contaminants penetrate from the outside, or when the dressing itself is contaminated with bacteria, there is a problem of becoming defenseless against bacterial infection.
따라서, 드레싱 자체의 세균 오염을 방지하기 위하여 제조 업체에서 고압멸균기를 통하여(감마멸균, EO gas멸균, 고온/고압) 멸균을 한 뒤 각급 의료기관에 유통시키고 있는데 유통 기간이 길어지면 외부환경에 의하여 오염이 발생될 가능성이 매우 크다. 기존 상처 치료용 드레싱은 직포나 부직포 형태로 구성되어 있으며, 사용되는 섬유의 직경이 수십 - 수백㎛로 구성되어 있어 바이러스나 외부오염물에 의한 2차 감염 등에 노출되어 있어 근본적인 개선이 요구되고 있는 실정이다.Therefore, in order to prevent bacterial contamination of the dressing itself, the manufacturer sterilizes it through an autoclave (gamma sterilization, EO gas sterilization, high temperature/high pressure) and distributes it to various medical institutions. It is very likely that this will happen. Existing wound healing dressings are composed of woven or non-woven fabrics, and the diameter of the fibers used is composed of several tens to hundreds of micrometers, and thus fundamental improvement is required because they are exposed to secondary infections caused by viruses or external contaminants. .
상기에서 언급한 문제점을 해결하기 위한 방법으로, 다양한 드레싱 소재에 은 나노 분말 또는 은 나노액체를 투입하여 제조된 은 나노입자가 함유된 것과 드레싱을 제조함에 있어 경사의 일정 간격 마다 은사를 첨가하는 것도 있었다.As a method to solve the above-mentioned problems, it is also possible to include silver nanoparticles prepared by injecting silver nanopowder or silver nanoliquid into various dressing materials, and adding silver threads at regular intervals of the inclination in manufacturing the dressing. there was.
은 이외에 금, 팔라듐, 백금, 구리 및 아연과 같은 귀금속은 피복재에서 효과적으로 세균을 죽이는 것으로 공지되어있다. 피복재에 이러한 귀금속의 사용은 또한 수많은 참고문헌에 공지되어 있다. 예를들면, Robert Edward Burrell 등(US 6,692,773 B2)은 100nm 이하의 그레인 사이즈를 갖는 나노결정 형태의 은, 금, 팔라듐 또는 백금, 또는 이들의 합금 또는 화합물과 같은 귀금속의 사용을 개시하는 바, 직물을 피막하여 항증식 효과를 갖는 피복재를 제공한다. Widemire(US 5,782,788)는 박테리아, 바이러스 및 진균류의 성장을 억제하기 위해 거즈패드상에 은 호일층의 고정을 개시한다. Fabo(US 5,340,363)은 탄성 실로 짜여지고 부드러운 실리콘 또는 폴리 우레탄 겔에 의해 피막화된 외부 흡수층 및 내부 다공성 소수층을 포함하는 피복재를 개시하는 바, 상기 겔은 항균제(예를들면, 아연)에 대한 담체, 통증-경감 물질 및 상처 회복을 자극하는 물질로서 사용될 수 있다.In addition to silver, precious metals such as gold, palladium, platinum, copper and zinc are known to effectively kill bacteria in cladding. The use of such noble metals in cladding is also known in numerous references. For example, Robert Edward Burrell et al. (US 6,692,773 B2) discloses the use of noble metals such as silver, gold, palladium or platinum in the form of nanocrystals having a grain size of 100 nm or less, or alloys or compounds thereof. To provide a coating material having an anti-proliferative effect by coating. Widemire (US 5,782, 788) discloses the immobilization of a layer of silver foil on a gauze pad to inhibit the growth of bacteria, viruses and fungi. Fabo (US 5,340,363) discloses a coating material comprising an outer absorbent layer and an inner porous hydrophobic layer woven with elastic yarn and encapsulated by a soft silicone or polyurethane gel, said gel being a carrier for an antimicrobial agent (e.g. zinc). , as a pain-relieving substance and as a substance stimulating wound healing.
상기 항균 금속을 포함한 상처에 직접 접촉되어 상처를 보호하면서 상처 치료를 촉진하는 상처용 드레싱재는 일반적으로 필름 형태의 드레싱과 폼 형태의 드레싱으로 구분된다.A dressing material for a wound that is in direct contact with the wound containing the antibacterial metal and promotes wound healing while protecting the wound is generally divided into a film-type dressing and a foam-type dressing.
필름으로된 드레싱은 상처부위를 습한 상태로 유지하여 상처 치유를 촉진시키는 반면, 상처 주위에 지나치게 많은 삼출물이 고이게 하여 주위의 피부가 짓무를 수 있다. 또한, 투습성을 향상시키기 위하여 추가적으로 물리/화학적으로 기공을 형성하는 것이 필요하다.While film-based dressings promote wound healing by keeping the wound moist, it can build up too much exudate around the wound and irritate the surrounding skin. In addition, in order to improve moisture permeability, it is necessary to additionally form pores physically/chemically.
한편, 폼으로 된 드레싱의 경우, 흡수성과 투습성이 우수한 반면, 두께가 두꺼워 피부 부착이 어렵고 부착이 가능하더라도 신축성이 없어 관절 등과 같은 부위에 적용되는 경우에는 들뜨게 되어 쉽게 떨어지는 문제점이 있다.On the other hand, in the case of a foam dressing, while excellent in absorbency and moisture permeability, it is difficult to attach to the skin because of its thick thickness and has no elasticity even if it is attached.
따라서, 흡수재로 활성탄소섬유를 이용하며 은나노 입자가 함침되어 있고, 상기 활성탄소섬유 상하면에 열가소성 폴리우레탄 나노층이 적층된 신축성 및 투습성이 개선된 새로운 드레싱 개발이 필요하다. Therefore, there is a need to develop a new dressing with improved elasticity and moisture permeability in which activated carbon fibers are used as absorbent materials, silver nanoparticles are impregnated, and thermoplastic polyurethane nanolayers are laminated on the upper and lower surfaces of the activated carbon fibers.
본 발명의 하나의 목적은 피부 밀착성과 신축성이 우수한 드레싱을 제공하는 것이다.One object of the present invention is to provide a dressing having excellent skin adhesion and elasticity.
본 발명의 다른 목적은 흡수도 및 투습도가 우수하고 소취성 및 항균성이 우수한 드레싱을 제공하는 것이다.Another object of the present invention is to provide a dressing having excellent absorbency and moisture permeability, and excellent deodorization and antibacterial properties.
상기와 같은 문제점을 해결하기 위해 본 발명은 활성탄소섬유 및 상기 활성탄소섬유 사이 공간 일부에 수지가 결합되고, 상기 수지의 내부 및 표면에 금속나노 입자가 결합된 흡수층으로 구성된 항균 부직포 드레싱을 제공한다. In order to solve the above problems, the present invention provides an antibacterial nonwoven dressing composed of an absorbent layer in which a resin is bonded to an activated carbon fiber and a part of the space between the activated carbon fibers, and metal nanoparticles are bonded to the inside and surface of the resin. .
또한, 본 발명은 상기 흡수층 일면 또는 양면에 나노섬유로 구성된 나노층이 적층된 것에 특징이 있는 항균 부직포 드레싱을 제공한다. In addition, the present invention provides an antibacterial nonwoven dressing, characterized in that a nanolayer composed of nanofibers is laminated on one or both surfaces of the absorbent layer.
또한, 본 발명의 상기 수지는 폴리우레탄(Polyurethane(PU)), 폴리비닐클로라이드(Poly(vinyl chloride)(PVC), 아크릴로니트릴부타디엔스티렌공중합체 (acrylonitrile butadiene styrene copolymer(ABS)), 폴리옥시메틸렌(poly Oxy Methylene(POM)), 폴리프로필렌(Polypropylene(PP)), 폴리에틸렌(Polyethylene(PE)),폴리페닐렌옥사이드(Polyphenylene oxide(PPO)), 폴리부틸렌테레프탈레이트(Polybutylene terephthalate(PBT)), 폴리에틸렌테레프탈레이트(Polyethylene terephthalate(PET)), 페놀(Phenol), 불소, 에폭시(Epoxy), 불포화폴리에스터(Unsaturated Polyester(UP)), 폴리메틸메타아크릴레이트(Polymethlymethacrylate(PMMA)), 폴리에테르에테르케톤(Polyetherether ketone(PEEK)), 폴리페닐렌설파이드(Polyphenylene sulfide(PPS)), 폴리아마이드(Polyamide(PA)), 폴리카보네이트(Polycarbonate(PC)) , 프로틴(Protein), 폴리(아스파르트산)(Poly(Aspartic Acid)), 폴리라틱산(Poly(L-Lactic Acid)), 폴리글리콜산(Poly(Glycolic Acid)), PLGA, 셀룰로오스(Cellulose), 콜라겐(Collagen), 젤라틴(Gelatin), 키틴(Chitin), 키토산(Chitosan) 중 어느 하나인 것에 특징이 있는 항균 부직포 드레싱을 제공한다. In addition, the resin of the present invention is polyurethane (Polyurethane (PU)), polyvinyl chloride (Poly (vinyl chloride) (PVC), acrylonitrile butadiene styrene copolymer (ABS)), polyoxymethylene (poly Oxy Methylene (POM)), polypropylene (PP), polyethylene (PE), polyphenylene oxide (PPO), polybutylene terephthalate (PBT)) , Polyethylene terephthalate (PET), Phenol, Fluorine, Epoxy, Unsaturated Polyester (UP), Polymethlymethacrylate (PMMA), Polyether ether Ketones (Polyetherether ketone (PEEK)), polyphenylene sulfide (PPS), polyamide (PA), polycarbonate (PC)), protein (Protein), poly (aspartic acid) ( Poly(Aspartic Acid)), Poly(L-Lactic Acid), Poly(Glycolic Acid), PLGA, Cellulose, Collagen, Gelatin, Chitin Chitin), provides an antibacterial nonwoven dressing characterized by any one of chitosan.
또한 본 발명의 상기 금속나노 입자는 나노 사이즈의 금, 은, 팔라듐, 백금, 구리, 아연 또는 이들의 합금 또는 화합물인 것에 특징이 있는 항균 부직포 드레싱을 제공한다. In addition, the metal nanoparticles of the present invention provide an antibacterial nonwoven dressing, characterized in that the nano-sized gold, silver, palladium, platinum, copper, zinc, or alloys or compounds thereof.
또한 본 발명은 상기 흡수층에 추가로 알코올계, 알데하이드계, 페놀계, 아미드계, 이미다졸계, 아졸계, 할로겐계의 적어도 어느 하나 이상으로 구성된 유기 항균제가 포함된 것에 특징이 있는 항균 부직포 드레싱을 제공한다. In addition, the present invention provides an antibacterial nonwoven dressing, characterized in that an organic antibacterial agent composed of at least one of alcohol-based, aldehyde-based, phenol-based, amide-based, imidazole-based, azole-based, and halogen-based organic antibacterial agents is added to the absorbent layer. to provide.
또한 본 발명의 상기 나노층은 한 개 이상의 나노섬유로 구성되며, 용융전기방사를 이용한 나노섬유가 적층된 것으로 신장율이 500%~1,000%인 것에 특징이 있는 항균 부직포 드레싱을 제공한다. In addition, the nanolayer of the present invention is composed of one or more nanofibers, and nanofibers using melt electrospinning are laminated, and provides an antibacterial nonwoven dressing, characterized in that the elongation is 500% to 1,000%.
또한 본 발명의 상기 나노섬유는 일반 고분자 수지, 생체접합성 고분자 수지 또는 천연 고분자 수지 중 어느 하나이며,In addition, the nanofiber of the present invention is any one of a general polymer resin, a biocompatible polymer resin, or a natural polymer resin,
상기 일반 고분자 수지는 폴리우레탄(Polyurethane(PU)), 폴리비닐클로라이드(Poly(vinyl chloride)(PVC), 아크릴로니트릴부타디엔스티렌공중합체 (acrylonitrile butadiene styrene copolymer(ABS)), 폴리옥시메틸렌(poly Oxy Methylene(POM)), 폴리프로필렌(Polypropylene(PP)), 폴리에틸렌(Polyethylene(PE)),폴리페닐렌옥사이드(Polyphenylene oxide(PPO)), 폴리부틸렌테레프탈레이트(Polybutylene terephthalate(PBT)), 폴리에틸렌테레프탈레이트(Polyethylene terephthalate(PET)), 페놀(Phenol), 불소, 에폭시(Epoxy), 불포화폴리에스터(Unsaturated Polyester(UP)), 폴리메틸메타아크릴레이트(Polymethlymethacrylate(PMMA)), 폴리에테르에테르케톤(Polyetherether ketone(PEEK)), 폴리페닐렌설파이드(Polyphenylene sulfide(PPS)), 폴리아마이드(Polyamide(PA)), 폴리카보네이트(Polycarbonate(PC)) 중 어느 하나이고,The general polymer resin is polyurethane (Polyurethane (PU)), poly(vinyl chloride) (PVC), acrylonitrile butadiene styrene copolymer (ABS), polyoxymethylene (poly Oxy) Methylene(POM)), polypropylene(PP), polyethylene(PE), polyphenylene oxide(PPO), polybutylene terephthalate(PBT), polyethylene terephthalate Phthalate (Polyethylene terephthalate (PET)), Phenol (Phenol), Fluorine, Epoxy, Unsaturated Polyester (UP), Polymethlymethacrylate (PMMA)), Polyetheretherketone (Polyetherether) ketone (PEEK)), polyphenylene sulfide (Polyphenylene sulfide (PPS)), polyamide (Polyamide (PA)), any one of polycarbonate (Polycarbonate (PC)),
상기 생체적합성 고분자는 프로틴(Protein), 폴리(아스파르트산)(Poly(Aspartic Acid)), 폴리라틱산(Poly(L-Lactic Acid)), 폴리글리콜산(Poly(Glycolic Acid)), PLGA 중 어느 하나이고, 상기 천연 고분자는 셀룰로오스(Cellulose), 콜라겐(Collagen), 젤라틴(Gelatin), 키틴(Chitin), 키토산(Chitosan) 중 어느 하나인 것에 특징이 있는 항균 부직포 드레싱을 제공한다. The biocompatible polymer is any one of protein (Protein), poly (aspartic acid) (Poly (Aspartic Acid)), poly (L-Lactic Acid), polyglycolic acid (Poly (Glycolic Acid)), PLGA One, and the natural polymer provides an antibacterial nonwoven dressing characterized in that any one of cellulose (Cellulose), collagen (Collagen), gelatin (Gelatin), chitin (Chitin), chitosan (Chitosan).
또한 본 발명의 상기 나노층은 초극세 섬유 집합체로 구성된 것으로, 상기 초극세 섬유 사이에 평균직경이 0.1㎛이상 10㎛미만의 소기공과 평균직경이 10㎛이상 50㎛미만의 대기공으로 구성된 것에 특징이 있는 항균 부직포 드레싱을 제공한다. In addition, the nanolayer of the present invention is composed of an ultrafine fiber aggregate, and between the ultrafine fibers, small pores having an average diameter of 0.1 μm or more and less than 10 μm and air pores having an average diameter of 10 μm or more and less than 50 μm Antibacterial characterized in that Non-woven dressings are provided.
본 발명의 드레싱재는 흡수성이 우수한 활성탄소섬유에 은나노 입자와 은나노 입자를 활성탄소섬유에 부착이 잘 될 수 있도록 도와주는 수지가 함침되어 항균성 및 지속성이 우수하다. 그래서 투습성 및 통기성이 우수하여 상처의 삼출물을 통과시켜 또 다른 드레싱에 삼출물 흡수에 도움을 주며, 우수한 항균지속성을 가져 수일 간 드레싱 교체가 필요 없이 사용 가능하다.The dressing material of the present invention is impregnated with silver nanoparticles and a resin that helps the silver nanoparticles to adhere well to the activated carbon fibers, so that the activated carbon fibers with excellent absorbency have excellent antibacterial properties and durability. Therefore, it has excellent moisture permeability and breathability, allowing exudates from wounds to pass through, helping to absorb exudates in another dressing, and has excellent antibacterial durability, so it can be used without changing the dressing for several days.
또한 본 발명은 상기 활성탄소섬유에 은나노 입자와 수지가 함침되어 있는 드래싱재의 양면 최외각층에 비부착성을 가진 폴리우레탄을 직접 전기방사하여 나노층을 구성할 수 있다.In addition, the present invention can form a nano-layer by directly electrospinning a polyurethane having non-adhesive properties on the outermost layers of both surfaces of the dressing material in which the activated carbon fibers are impregnated with silver nanoparticles and resin.
또한, 본 발명은 신장률 및 탄성복원력이 우수하여 부상 부위에 사용시 탄력성 있는 지지대 역할을 하여 안정감과 편안함을 줄 수 있다.In addition, the present invention can provide stability and comfort by serving as an elastic support when used on an injured site due to excellent elongation and elastic restoring force.
도 1은 본 발명에 대한 구성 및 기능에 대한 설명도이다.
도 2, 3은 본 발명에 대한 개념도이다. 1 is an explanatory diagram for the configuration and function of the present invention.
2 and 3 are conceptual diagrams of the present invention.
이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 우선, 본 발명을 설명함에 있어, 관련된 공지기능 혹은 구성에 대한 구체적인 설명은 본 발명의 요지를 모호하지 않게 하기 위하여 생략한다.Hereinafter, preferred embodiments of the present invention will be described in detail. First, in describing the present invention, detailed descriptions of related known functions or configurations are omitted so as not to obscure the gist of the present invention.
본 명세서에서 사용되는 정도의 용어 '약', '실질적으로' 등은 언급된 의미에 고유한 제조 및 물질 허용오차가 제시될 때 그 수치에서 또는 그 수치에 근접한 의미로 사용되고, 본 발명의 이해를 돕기 위해 정확하거나 절대적인 수치가 언급된 개시 내용을 비양심적인 침해자가 부당하게 이용하는 것을 방지하기 위해 사용된다.As used herein, the terms 'about', 'substantially' and the like are used in or close to the numerical value when manufacturing and material tolerances inherent in the stated meaning are presented, and provide an understanding of the present invention. To help, precise or absolute figures are used to prevent unfair use by unscrupulous infringers of the stated disclosure.
이하에서 첨부 도면을 참고하여 본 발명에 대하여 더욱 상세하게 설명한다. 본 발명을 설명함에 있어서, 관련된 공지의 범용적인 기능 또는 구성에 대한 상세한 설명은 생략한다.Hereinafter, the present invention will be described in more detail with reference to the accompanying drawings. In describing the present invention, detailed descriptions of related known general-purpose functions or configurations will be omitted.
본 명세서에서 “초극세 섬유”라 함은 약 0.1 내지 10㎛의 직경을 갖는 섬유를 의미한다. As used herein, the term “ultrafine fibers” refers to fibers having a diameter of about 0.1 to 10 μm.
“섬유 집합체”란 섬유를 직조공정을 거치지 않고, 평행 또는 부정방향으로 배열하고 섬유가 서로 얽히도록 기계적인 처리를 하여 만든 것으로 부직포가 하나의 예이다. “Fiber aggregate” refers to a nonwoven fabric made by arranging fibers in parallel or negative directions without going through a weaving process and mechanically treating the fibers to become entangled with each other.
도 1은 본 발명에 대한 구성 및 기능에 대한 설명도이며, 도 2,3은 본 발명에 대한 개념도이다.1 is an explanatory diagram for the configuration and function of the present invention, and Figures 2 and 3 are conceptual diagrams for the present invention.
본 발명은 활성탄소섬유(33) 및 상기 활성탄소섬유(33) 사이 공간 일부에 수지(30)가 결합되고, 상기 수지(30)의 내부 및 표면에 금속나노 입자(31)가 결합된 흡수층(10)으로 구성되며, 필요에 따라서는 상기 흡수층 일면 또는 양면에 나노섬유로 구성된 나노층(20)을 추가로 적층시켜 사용할 수 있다. The present invention relates to an absorption layer in which a
활성탄소섬유(33)는 탄소섬유의 10Å 미만의 미세기공을 발달시킨 것으로 비표면적이 크며 흡착속도가 빠르고 흡착용량이 큰 고성능 흡착재료이다. 기상흡착 분야뿐만 아니라 고도정수처리 분야에 있어서도 활성탄을 대체할 수 있는 새로운 수처리제로 가능하며 본 발명인 드레싱에서는 상처 삼출물을 빠른 시간에 흡수할 수 있으며, 상처 부위의 각종 냄새도 함께 제거가 가능하다. The activated
활성탄소섬유(33)는 섬유의 특성을 그대로 보유하고 있으므로 직포, 부직포, 종이 등의 형태로 가공하여 취급하기 매우 편리하여 다양한 분야에 사용될 수 있고 본 발명에서는 부직포 또는 섬유 집합체로 사용될 수 있다. Since the activated
본 발명은 상기 활성탄소섬유(33)를 나노 사이즈의 금, 은, 팔라듐, 백금, 구리, 아연 또는 이들의 합금 또는 화합물 중 적어도 어느 하나인 금속나노 입자(31)가 포함된 폴리우레탄 수지(30) 용액에 함침시킨 후 상기 금속 등이 첨착된 활성탄소섬유를 건조기에서 24시간 이상 건조시킨다.The present invention is a polyurethane resin (30) containing the activated carbon fiber (33) of the nano-sized metal nanoparticles (31) at least any one of gold, silver, palladium, platinum, copper, zinc, or alloys or compounds thereof. ) After impregnating with the solution, the activated carbon fiber to which the metal is attached is dried in a dryer for at least 24 hours.
또한 상기 수지 용액의 용매로 물 이외에 극성용매인 DMA(dimethylacetamide), DMSO(dimethyl solfoxide), HMPA(hexamethylphosphoric acid) 등을 혼합사용할 수 있다. In addition, as a solvent of the resin solution, a polar solvent such as dimethylacetamide (DMA), dimethyl solfoxide (DMSO), hexamethylphosphoric acid (HMPA), etc. may be mixed and used in addition to water.
수지는 물에 녹거나 물에 풀리는 성질의 수지로 일반 고분자 수지이외에 생체적합성 고분자 수지 및 천연 고분자 수지로 사용할 수 있다. Resins are water-soluble or water-soluble resins, and can be used as biocompatible polymer resins and natural polymer resins in addition to general polymer resins.
일반 고분자 수지는 폴리우레탄(Polyurethane(PU)), 폴리비닐클로라이드(Poly(vinyl chloride)(PVC), 아크릴로니트릴부타디엔스티렌공중합체 (acrylonitrile butadiene styrene copolymer(ABS)), 폴리옥시메틸렌(poly Oxy Methylene(POM)), 폴리프로필렌(Polypropylene(PP)), 폴리에틸렌(Polyethylene(PE)),폴리페닐렌옥사이드(Polyphenylene oxide(PPO)), 폴리부틸렌테레프탈레이트(Polybutylene terephthalate(PBT)), 폴리에틸렌테레프탈레이트(Polyethylene terephthalate(PET)), 페놀(Phenol), 불소, 에폭시(Epoxy), 불포화폴리에스터(Unsaturated Polyester(UP)), 폴리메틸메타아크릴레이트(Polymethlymethacrylate(PMMA)), 폴리에테르에테르케톤(Polyetherether ketone(PEEK)), 폴리페닐렌설파이드(Polyphenylene sulfide(PPS)), 폴리아마이드(Polyamide(PA)), 폴리카보네이트(Polycarbonate(PC))가 있으며,General polymer resins are polyurethane (Polyurethane (PU)), poly(vinyl chloride) (PVC), acrylonitrile butadiene styrene copolymer (ABS), polyoxymethylene (poly Oxy Methylene) (POM)), polypropylene (PP), polyethylene (PE), polyphenylene oxide (PPO), polybutylene terephthalate (PBT), polyethylene terephthalate (Polyethylene terephthalate (PET)), Phenol, Fluorine, Epoxy, Unsaturated Polyester (UP), Polymethlymethacrylate (PMMA), Polyetherether ketone (PEEK)), polyphenylene sulfide (PPS), polyamide (PA), polycarbonate (PC),
생체적합성 고분자는 프로틴(Protein), 폴리(아스파르트산)(Poly(Aspartic Acid)), 폴리라틱산(Poly(L-Lactic Acid)), 폴리글리콜산(Poly(Glycolic Acid)), PLGA 등이 있고,Biocompatible polymers include Protein, Poly(Aspartic Acid), Poly(L-Lactic Acid), Poly(Glycolic Acid), PLGA, etc. ,
천연 고분자는 셀룰로오스(Cellulose), 콜라겐(Collagen), 젤라틴(Gelatin), 키틴(Chitin), 키토산(Chitosan) 등이 있다. Natural polymers include cellulose, collagen, gelatin, chitin, and chitosan.
금속나노 입자(31)에서 금속의 종류로 은 금, 은, 팔라듐, 백금, 구리, 아연 또는 이들의 합금 또는 화합물이 가능하며 모두 피복재에서 효과적으로 세균을 죽이는 것으로 알려진 물질이며, 특히 은 금속이 가장 항균성에 효과적이다. As the type of metal in the
특히 은(Ag)은 금속분말로 사용할 수 있고, 은 금속염으로도 사용 가능하다. 상기 은 금속염은 질산은, 황산은, 염화은 등을 사용할 수 있다.In particular, silver (Ag) can be used as a metal powder, and can also be used as a silver metal salt. As the silver metal salt, silver nitrate, silver sulfate, silver chloride, or the like may be used.
또한, 유기 항균제인 알코올계, 알데하이드계, 페놀계, 아미드계, 이미다졸계, 아졸계, 할로겐계를 흡수층의 수지와 혼합사용가능하다. In addition, alcohol-based, aldehyde-based, phenol-based, amide-based, imidazole-based, azole-based, and halogen-based organic antibacterial agents may be mixed with the resin of the absorption layer.
다음으로 본 발명은 추가로 상기 흡수층(10) 일면 또는 양면에 나노섬유로 구성된 나노층(20)이 적층되어 사용될 수 있다. Next, according to the present invention, a
본 발명은 흡수층(10)이 금속나노 입자(31)가 포함된 수지(30) 용액에 함침된 후 건조된 것으로 상기 흡수층(10) 내부 및 표면의 활성탄소섬유 섬유 사이 공간 일부를 금속나노 입자(31)와 함께 수지(30)가 흘러들어가서 경화된다. 경화된 수지 내부 및 외부 표면에 금속나노 입자(31)가 결합된 구조이다. 따라서, 상기 흡수층(10)의 내부 공간의 일부는 빈 공간으로 존재하여 공기가 통과할 수 있는 기공을 갖고 있다. According to the present invention, the
또한 흡수층(10)과 나노층(20)의 적층 계면에 있어서 조성물은 유사한 것이 바람직하며 결과적으로 추가 접착제 또는 접착필름이 필요 없어, 흡수층(10)의 기공과 나노섬유로 구성된 나노층(20)의 기공이 별도의 접착제 또는 접착필름을 사용하지 않으므로 기공의 연속성이 유지가 되어 흡수성 및 통기성에 유리한 특징이 있다. In addition, it is preferable that the composition is similar at the lamination interface of the
상기 나노섬유로 구성된 나노층(20)은 용융전기방사를 통한 나노섬유로 적층된 것으로 신장율이 500%~1,000%인 것에 특징이 있다. The
흡수층(10)의 수지(30)의 종류와 유사한 종류의 수지로 나노층(20)의 나노섬유를 전기방사하여 적층시키는 것이 바람직하며, 유사한 종류의 구분은 흡수층(10)에 상용된 수지(30)와 마찬가지로 나노섬유도 일반 고분자 수지, 생체적합성 고분자 수지, 천연 고분자 수지로 구될 수 있으며 같은 구분의 수지를 사용하면 바람직하고 더 바람직하게는 동일한 수지를 사용하는 것이 타당하다. It is preferable to laminate the nanofibers of the
용융전기방사란 섬유 원료 용융액을 하전상태에서 방사하여 미세 직경의 섬유를 제조하는 기술이다. 용융 전기방사법은 솔벤트를 사용하지 않고 고분자 용융액만을 사용하여 섬유를 제조하기 때문에 잔류 솔벤트로 인한 유해한 효과가 전혀 없어, 특히 제조된 웹을 창상 치료용 드레싱재 등으로 이용하는데 유용하다. Melt electrospinning is a technology for producing micro-diameter fibers by spinning a melted fiber raw material in a charged state. The melt electrospinning method does not use a solvent and only uses a polymer melt to produce fibers, so there is no harmful effect due to residual solvent, and in particular, it is useful for using the prepared web as a dressing material for wound treatment.
이러한 용융 전기방사법은 전극의 한 극은 방사노즐부에, 다른 한 극은 콜렉터에 위치한 서로 반대 극성을 가지는 두 전극 사이에서, 하전된 고분자 용융액을 방사노즐부를 거쳐 공기중으로 토출하고, 이어서 공기 중에서 하전 필라멘트의 연신 및 또 다른 필라멘트 분기를 거쳐 극세섬유를 제조하는 방법이다. 즉, 하전된 토출 필라멘트는 노즐과 콜렉터 사이에 형성된 전기장 내에서 상호 반발 등 전기적 영향으로 심한 요동을 거치면서 극세화된다.In this melt electrospinning method, between two electrodes having opposite polarities, one pole of the electrode is located in the spinning nozzle part and the other pole in the collector, the charged polymer melt is discharged into the air through the spinning nozzle part, and then charged in the air. It is a method of manufacturing microfibers by stretching a filament and branching another filament. That is, the charged discharge filament is microscopic while undergoing severe fluctuations due to electrical influences such as mutual repulsion in the electric field formed between the nozzle and the collector.
이 때, 초극세 섬유 부직포를 구성하는 초극세 섬유의 직경은 전기방사시의 조건을 적절히 조절함으로써 조절될 수 있다.In this case, the diameter of the ultrafine fibers constituting the ultrafine fiber nonwoven fabric can be adjusted by appropriately adjusting the conditions during electrospinning.
본 발명의 일 구현 예에 따른 나노층(20)은 바람직하게는 극세사의 평균직경이 0.1~10㎛이고, 단위면적당 중량이 1.0g/㎡~10g/㎡이며, 두께가 10㎛~100㎛인 것이 바람직하다.The
또한, 본 발명의 일 구현예에 따른 나노층(20)는, BS EN 13726-1:2002으로 측정한 투습도가 5000g/㎡24시간 이상으로 우수한 투습 특성을 나타낸다. In addition, the
본 발명에서 사용되는 수지 중에 열가소성 폴리우레탄은 공지된 폴리우레탄 반응기술을 사용하여 제조할 수 있다. 예컨대, 폴리알킬렌에테르글리콜에 과잉 몰의 유기디이소시아네이트를 아미드계 극성용매 중에서 반응시켜 말단에 이소시아네이트기를 갖는 중간중합체를 조제하고, 이어서, 이러한 중간중합체를 아미드계 극성용매에 용해하고 사슬연장제와 말단정지제를 반응시킴으로써 폴리우레탄 중합체를 얻을 수 있다. 열가소성 폴리우레탄은 선형 구조의 거대한 분자 구조로 인해서 열가소성을 띄고, 일반적인 폴리우레탄과는 달리 열가소성 폴리우레탄을 제조하기 위해서는 연쇄 부가 반응을 거쳐야 한다. Among the resins used in the present invention, thermoplastic polyurethane can be prepared using a known polyurethane reaction technique. For example, by reacting an excess mole of organic diisocyanate with polyalkylene ether glycol in an amide-based polar solvent to prepare an intermediate polymer having an isocyanate group at the terminal, the intermediate polymer is then dissolved in an amide-based polar solvent and combined with a chain extender A polyurethane polymer can be obtained by reacting a terminator. Thermoplastic polyurethane is thermoplastic due to its large molecular structure of linear structure, and unlike general polyurethane, a chain addition reaction is required to produce thermoplastic polyurethane.
또한 열가소성 폴리우레탄의 선형 구조를 얻기 위해서는 2개의 관능기를 가진 MDI를 아디픽산(Adipic acid), 글리콜(Glycol)과 부탄디올(Butanediol)로 제조된 선형 폴리에스터 폴리올(Polyesterol) 또는 폴리테트라하이드로퓨란(Polytetrahydrofuran)과 반응을 시킨다. 열가소성 폴리우레탄의 탄성체적인 물성은 고분자 연쇄 부가 반응시에 생기는 상분리 현상에 영향을 받는다. 즉, MDI와 폴리올 그리고 MDI와 부탄디올의 반응 생성물로부터 상분리가 일어난다. In addition, in order to obtain the linear structure of the thermoplastic polyurethane, MDI having two functional groups is used as a linear polyester polyol made of adipic acid, glycol and butanediol or polytetrahydrofuran. ) and react. The elastomeric properties of the thermoplastic polyurethane are affected by the phase separation that occurs during the polymer chain addition reaction. That is, phase separation occurs from the reaction product of MDI and polyol and MDI and butanediol.
친수성 폴리우레탄 프리폴리머의 제조에 있어서는 바람직하게는 이소시아네이트 1~3몰에 대해 폴리에테르폴리올류 0.15~0.95 몰비로 합성하여 제조한다.In the production of the hydrophilic polyurethane prepolymer, it is preferably prepared by synthesizing the polyether polyol in a molar ratio of 0.15 to 0.95 to 1 to 3 moles of isocyanate.
이소시아네이트로는 이소포론 디이소시아네이트, 2,4-톨루엔디이소시아네이트 및 그 이성질체, 디페닐메탄디이소시아네이트, 헥사메틸렌디이소시아네이트, 라이신디이소시아네이트, 트리메틸헥사메틸렌디이소시아네이트, 비스(2-이소시아네이트에텔)-퓨마레이트, 3,3'-디메틸-4,4'-디페닐메탄디이소시아네이트, 1,6-헥산디이소시아네이트, 4,4'-바이페닐렌디이소시아네이트, 3,3'-디메틸페닐렌디이소시아네이트, p-페닐렌디이소시아네이트, m-페닐렌디이소시아네이트, 1,5-나프탈렌디이소시아네이트, 1,4-자일렌디이소시아네이트, 1,3-자일렌디이소시아네이트 등을 사용할 수 있으며, 바람직하게는 디페닐메탄디이소시아네이트, 2,4-톨루엔디이소시아네이트 및 그 이성질체, p-페닐렌디이소시아네이트, 이소포론디이소시아네이트, 헥사메틸렌디이소시아네디트를 사용하는 편이 좋다.As isocyanate, isophorone diisocyanate, 2,4-toluene diisocyanate and its isomers, diphenylmethane diisocyanate, hexamethylene diisocyanate, lysine diisocyanate, trimethylhexamethylene diisocyanate, bis(2-isocyanate ether)-fumarate , 3,3'-dimethyl-4,4'-diphenylmethane diisocyanate, 1,6-hexane diisocyanate, 4,4'-biphenylene diisocyanate, 3,3'-dimethylphenylene diisocyanate, p-phenyl Rendiisocyanate, m-phenylene diisocyanate, 1,5-naphthalene diisocyanate, 1,4-xylene diisocyanate, 1,3-xylene diisocyanate, etc. can be used, Preferably diphenylmethane diisocyanate, 2,4 -Toluene diisocyanate and its isomers, p-phenylene diisocyanate, isophorone diisocyanate, and hexamethylene diisocyanate are better to be used.
폴리에테르폴리올류는 분자내에 3개 이상의 수산기를 갖고 분자량이 3,000~6,000이며 에틸렌옥사이드 함량이 50~80%인 에틸렌옥사이드/프로필렌옥사이드 랜덤공중합체와 분자내에 2개 이상의 수산기를 갖고 분자량이 1,000~4,000인 폴리프로필렌글리콜 중량 대비 30:70으로 혼합하여 사용할 수 있으며, 바람직하게는 분자내에 3개의 수산기를 갖고 분자량이 3,000~6,000이며 에틸렌옥사이드 함량이 50%~80%인 에틸렌옥사이드/프로필렌옥사이드 랜덤 공중합체를 단독으로 사용하는 편이 좋다. 그러나 물성조절을 위하여 상기에서 언급하지 않은 타 이소시아네이트화합물과 폴리올류를 혼합 사용할 수 있다.Polyether polyols are ethylene oxide/propylene oxide random copolymers having three or more hydroxyl groups in the molecule, molecular weight of 3,000 to 6,000, and ethylene oxide content of 50 to 80%, and two or more hydroxyl groups in the molecule and molecular weight of 1,000 to 4,000. An ethylene oxide/propylene oxide random copolymer having a molecular weight of 3,000 to 6,000 and an ethylene oxide content of 50% to 80%. It is better to use it alone. However, in order to control the physical properties, a mixture of other isocyanate compounds and polyols not mentioned above may be used.
열가소성 폴리우레탄 칩이 준비되면 상기 폴리우레탄 칩을 방사구금과 콜렉터 사이에 전압이 인가된 상태하에서, 전기방사에 의해 콜렉터 상에 방사하여 초극세 섬유 웹을 형성한다. 이때, 콜렉터의 속도를 0.5m/min 내지 1m/min의 느린 속도로 방사하여 평균직경이 0.1㎛이상 10㎛미만인 소기공을 갖는 섬유 웹을 수득하고, 이어서 콜렉터의 속도를 5m/min 내지 10 m/min의 빠른 속도로 방사하여 평균직경이 10㎛이상 50㎛미만인 대기공을 갖는 섬유 웹을 수득할 수 있다. When the thermoplastic polyurethane chip is prepared, the polyurethane chip is spun on the collector by electrospinning under a voltage applied between the spinneret and the collector to form an ultrafine fiber web. At this time, the speed of the collector was spun at a slow speed of 0.5 m/min to 1 m/min to obtain a fibrous web having small pores having an average diameter of 0.1 μm or more and less than 10 μm, and then the speed of the collector was changed from 5 m/min to 10 m. It is possible to obtain a fibrous web having air pores having an average diameter of 10 μm or more and less than 50 μm by spinning at a high speed of /min.
본 발명의 구현 예들에서는 필요에 따라 콜렉터의 속도 및 방사 시간을 조절하여 소기공과 대기공을 소정의 비율로 포함하는 섬유 웹을 조절할 수 있다. In embodiments of the present invention, the fibrous web including small pores and large pores in a predetermined ratio may be adjusted by adjusting the speed and spinning time of the collector as necessary.
또한, 소기공을 갖는 섬유 웹을 수득하는 단계와 대기공을 갖는 섬유 웹을 수득하는 단계를 2회 이상 반복 실시하는 것도 가능하다. 이러한 열가소성 초극세 폴리우레탄 초극세 섬유가 전기방사되면서 동시에 3차원의 네트워크로 융착되어 다공성 나노층(20)를 형성한다. 따라서 기재가 없더라도 소정의 두께의 나노층(20)을 제조할 수 있다. It is also possible to repeat the steps of obtaining a fibrous web having small pores and obtaining a fibrous web having large pores twice or more. These thermoplastic ultrafine polyurethane ultrafine fibers are electrospun and simultaneously fused into a three-dimensional network to form the
이하에서 실시예를 들어 본 발명을 보다 상세하게 설명할 것이다. 이러한 실시예는 본 발명의 바람직한 구현예들을 설명하기 위한 것으로, 본 발명의 보호범위가 이들 실시예에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail by way of examples. These examples are intended to illustrate preferred embodiments of the present invention, and the protection scope of the present invention is not limited by these examples.
실시예Example 1 One
0.1mm×20mm×40mm 사이즈의 활성탄소섬유(ACF)15g을 105℃의 오븐에서 24시간 이상 건조시킨 다음 은 나노입자가 있는 폴리우레탄 수지 용액에 함침 시킨다. 균일한 함침을 위해 코팅바를 이용하여 은 나노가 함침된 ACF를 밀어준다. 그 후에 ACF를 150℃오븐에 넣고, 24시간이상 건조시킨다.After drying 15 g of activated carbon fiber (ACF) with a size of 0.1 mm × 20 mm × 40 mm in an oven at 105° C. for more than 24 hours, it is impregnated in a polyurethane resin solution with silver nanoparticles. For uniform impregnation, the ACF impregnated with silver nano is pushed by using a coating bar. After that, the ACF is placed in an oven at 150° C. and dried for at least 24 hours.
실시예Example 2 2
실시예 1의 흡수층의 상하면에 직접 전기방사하며 평량 1g/m2으로 맞춘다. 전기방사방법은 아래와 같다.Electrospinning is performed directly on the upper and lower surfaces of the absorption layer of Example 1, and the basis weight is adjusted to 1 g/m 2 . The electrospinning method is as follows.
100ppm이하 수분율로 관리되는 MI(melt index)가 224℃에서 60g/10min인 열가소성 폴리우레탄을 사용하여 40mm, L/D=25인 단일 스크류(single screw)의 압출기에서 각단을 Z1, Z2, Z3로 할 때, Z1의 온도를 210 내지 230℃, Z2의 온도를 180 내지 190℃ 및 Z3의 온도를 210 내지 230℃로 설정하고 최종 방사 빔(spinning veam)의 온도를 200℃에서 기어 펌프 속도를 5~30rpm으로 조절해가면서 전기방사 하였다. 전기방사시 방사구금의 전압은 50kv로 인가하였고, 콜렉터의 전압은 -30 내지 -50kv로 인가하였다. 이때, 콜렉터의 속도를 0.8 m/min으로 조절하여 미세기공을 갖는 섬유 웹을 집적한 후 콜렉터의 속도를 7m/min로 증가시켜 방사하여 대기공을 갖는 섬유 웹을 얻는 과정을 3차례 반복하였다. TCD(Tip to collector distance)은 20~50cm범위로 하였으며, 홀당 폴리머 0.1 내지 0.2g가 토출되어 나노층(20)을 형성하였다. 전기방사에 의해 수득된 초극세 나노층(20)을 100℃에서 캘린더링하여 항균 부직포 드레싱을 제조하였다. Using a thermoplastic polyurethane with an MI (melt index) of 60g/10min at 224℃, managed with a moisture content of less than 100ppm, in a single screw extruder with 40mm and L/D=25, each end is divided into Z1, Z2, and Z3. When doing this, set the temperature of Z1 to 210 to 230°C, the temperature of Z2 to 180 to 190°C, and the temperature of Z3 to 210 to 230°C, and set the temperature of the final spinning beam to 200°C and the gear pump speed to 5 Electrospinning was performed while controlling the speed to ~30 rpm. During electrospinning, the voltage of the spinneret was applied at 50 kv, and the voltage of the collector was applied at -30 to -50 kv. At this time, the process of obtaining a fibrous web having large pores was repeated three times by adjusting the speed of the collector to 0.8 m/min to collect the fiber web having micropores, and then increasing the speed of the collector to 7 m/min and spinning it. The tip to collector distance (TCD) was in the range of 20 to 50 cm, and 0.1 to 0.2 g of polymer per hole was discharged to form the
비교예comparative example 1 One
Exciton Technologies사의 exsalt SD7 Wound Dressing Exsalt SD7 Wound Dressing from Exciton Technologies
비교예comparative example 2 2
CalgonCarbon사의 zorflex wound dressingCalgonCarbon zorflex wound dressing
비교예comparative example 3 3
Smith & nephew 사의 Acticoat dressingActicoat dressing by Smith & nephew
비교예comparative example 4 4
Bio-medical Carbon Technology사의 Kocarbon Ag 실버 탄소 상처 dressingKocarbon Ag silver carbon wound dressing from Bio-medical Carbon Technology
<물성 평가><Evaluation of physical properties>
1. 인장특성 평가1. Evaluation of tensile properties
인장변형율 및 인장응력은 만능시험기계(이하 UTM)을 사용하여 측정하였다. Cross head speed는 100mm/min으로 시편이 파단이 될 때까지를 최종신율로 계산하였고 그때의 stress를 인장응력으로 정의하여 비교하였다. 시편의 치수는 KS M3054의 플라스틱 필름 및 시트의 인장 시험방법 규격의 1호형 시험편을 기준하여 준비하였다.Tensile strain and tensile stress were measured using a universal testing machine (hereinafter referred to as UTM). The cross head speed was calculated as the final elongation until the specimen broke at 100 mm/min, and the stress at that time was defined as the tensile stress and compared. The dimensions of the specimen were prepared based on the No. 1 test piece of the KS M3054 plastic film and sheet tensile test method specification.
2. 투습도 평가2. Water vapor permeability evaluation
실시예 및 비교예를 내부직경 35.7±0.1mm, 단면적 10cm2 사이즈로 하여 BS EN 13726-1:2002으로 투습성을 평가한 결과를 하기 표 1에 나타내었다.Examples and Comparative Examples were evaluated for moisture permeability in accordance with BS EN 13726-1:2002 with an inner diameter of 35.7±0.1mm and a cross-sectional area of 10cm 2 in size, as shown in Table 1 below.
3. 소취도 평가 3. Deodorization evaluation
실시예 및 비교예를 10cm x 10 cm 사이즈로 하여 환경 표지 인증 기준(EL608)에 의해 2시간 동안 tedlar bag에 암모니아가스(NH3)와 시료를 함께 넣어 암모니아가스(NH3)의 잔류량을 검지관으로 확인하여 백분율로 평가하였다. Examples and Comparative Examples are 10 cm x 10 cm in size, and ammonia gas (NH3) and a sample are put together in a tedlar bag for 2 hours according to the environmental label certification standard (EL608), and the residual amount of ammonia gas (NH3) is checked with a detection tube to evaluate as a percentage
4. 항균성 평가4. Antimicrobial evaluation
ASTM E2149-10에 의거하여 실시예 1 및 비교예 1 내지 4의 시료를 10±01g 로 준비한 후, 각 시료별로 무균 250ml 진탕플라스크를 준비하여 세균 접종물의 실행 희석액 50±05ml를 각 플라스크에 추가하였다. 각 플라스크 속에 실시예 1 및 비교예 1 내지 4의 시료를 각각 배치한 후, 각 플라스크들을 진탕기(wrist-action shaker) 위에 놓고 60±5분 동안 최대 속도로 흔들고 희석하여 평판 배지에 분주하고 24시간, 35±2℃ 인큐베이터에서 배양한 후 현미경으로 배양 페드리디쉬 내 집락수를 확인하였다. 하기 식에 의해 계산한 항균성을 계산하였다. According to ASTM E2149-10, 10 ± 01 g of the samples of Example 1 and Comparative Examples 1 to 4 were prepared, and then a sterile 250 ml shaking flask was prepared for each sample, and 50 ± 05 ml of a running dilution of the bacterial inoculum was added to each flask. . After placing each of the samples of Example 1 and Comparative Examples 1 to 4 in each flask, each flask was placed on a wrist-action shaker, shaken at maximum speed for 60±5 minutes, diluted, and dispensed on a plate medium 24 Time, after culturing in an incubator at 35±2° C., the number of colonies in the cultured fedri dish was checked under a microscope. The antibacterial properties calculated by the following formula were calculated.
항균력(%) = (B-A)/B × 100Antibacterial activity (%) = (B-A)/B × 100
A: 시료와 세균 희석액의 접촉시간 이후 세균수A: Number of bacteria after contact time between sample and bacterial dilution
B: 시료를 처리하지 않은 대조군의 세균수B: the number of bacteria in the control group not treated with the sample
* 음성대조군은 100%, 양성대조군 5.4% * Negative control is 100%, positive control is 5.4%
이상에서 본 발명의 바람직한 구현예를 예로 들어 상세하게 설명하였으나, 이러한 설명은 단순히 본 발명의 예시적인 실시예를 설명 및 개시하는 것이다. 당업자는 본 발명의 범위 및 정신으로부터 벗어남이 없이 상기 설명 및 첨부 도면으로부터 다양한 변경, 수정 및 변형예가 가능함을 용이하게 인식할 것이며, 그러한 변형이나 변경은 본 발명의 특허청구범위에 속하는 것으로 해석되어야 한다. In the above, the preferred embodiments of the present invention have been described in detail as an example, but these descriptions merely describe and disclose exemplary embodiments of the present invention. Those skilled in the art will readily recognize that various changes, modifications and variations are possible from the foregoing description and accompanying drawings without departing from the scope and spirit of the present invention, and such modifications and variations should be construed as falling within the scope of the claims of the present invention. .
10 : 흡수층 20 : 나노층
30 : 수지 31 : 금속나노 입자
33 : 활성탄소섬유10: absorption layer 20: nano layer
30: resin 31: metal nanoparticles
33: activated carbon fiber
Claims (8)
상기 수지의 내부 및 표면에 금속나노 입자가 결합된 흡수층 및
상기 흡수층 일면 또는 양면에 직접 용융전기방사에 의한 나노섬유로 적층된 나노층으로 구성되되,
상기 나노섬유의 신장율이 500%~1,000%인 것에 특징이 있는 항균 부직포드레싱
A resin is bonded to a part of the space between the activated carbon fiber and the activated carbon fiber,
an absorption layer in which metal nanoparticles are bonded to the inside and surface of the resin; and
It is composed of a nanolayer laminated with nanofibers by direct melt electrospinning on one or both sides of the absorption layer,
Antibacterial nonwoven dressing, characterized in that the elongation of the nanofiber is 500% to 1,000%
상기 수지는 폴리우레탄(Polyurethane(PU)), 폴리비닐클로라이드(Poly(vinyl chloride)(PVC), 아크릴로니트릴부타디엔스티렌공중합체 (acrylonitrile butadiene styrene copolymer(ABS)), 폴리옥시메틸렌(poly Oxy Methylene(POM)), 폴리프로필렌(Polypropylene(PP)), 폴리에틸렌(Polyethylene(PE)),폴리페닐렌옥사이드(Polyphenylene oxide(PPO)), 폴리부틸렌테레프탈레이트(Polybutylene terephthalate(PBT)), 폴리에틸렌테레프탈레이트(Polyethylene terephthalate(PET)), 페놀(Phenol), 불소, 에폭시(Epoxy), 불포화폴리에스터(Unsaturated Polyester(UP)), 폴리메틸메타아크릴레이트(Polymethlymethacrylate(PMMA)), 폴리에테르에테르케톤(Polyetherether ketone(PEEK)), 폴리페닐렌설파이드(Polyphenylene sulfide(PPS)), 폴리아마이드(Polyamide(PA)), 폴리카보네이트(Polycarbonate(PC)) , 프로틴(Protein), 폴리(아스파르트산)(Poly(Aspartic Acid)), 폴리라틱산(Poly(L-Lactic Acid)), 폴리글리콜산(Poly(Glycolic Acid)), PLGA, 셀룰로오스(Cellulose), 콜라겐(Collagen), 젤라틴(Gelatin), 키틴(Chitin), 키토산(Chitosan) 중 어느 하나인 것에 특징이 있는 항균 부직포 드레싱.
According to claim 1,
The resin is polyurethane (Polyurethane (PU)), polyvinyl chloride (Poly (vinyl chloride) (PVC), acrylonitrile butadiene styrene copolymer (ABS)), polyoxymethylene (poly Oxy Methylene ( POM)), polypropylene (PP), polyethylene (PE), polyphenylene oxide (PPO), polybutylene terephthalate (PBT), polyethylene terephthalate ( Polyethylene terephthalate (PET)), Phenol, Fluorine, Epoxy, Unsaturated Polyester (UP), Polymethlymethacrylate (PMMA), Polyetherether ketone ( PEEK)), polyphenylene sulfide (PPS), polyamide (PA)), polycarbonate (PC) , protein (Protein), poly (aspartic acid) (Poly (Aspartic Acid) ), Poly(L-Lactic Acid), Poly(Glycolic Acid), PLGA, Cellulose, Collagen, Gelatin, Chitin, Chitosan ( Chitosan) antibacterial non-woven dressing characterized by any one of.
상기 금속나노 입자는 나노 사이즈의 금, 은, 팔라듐, 백금, 구리, 아연 또는 이들의 합금 또는 화합물인 것에 특징이 있는 항균 부직포 드레싱.
According to claim 1,
The metal nanoparticles are antibacterial nonwoven dressing, characterized in that the nano-sized gold, silver, palladium, platinum, copper, zinc or alloys or compounds thereof.
상기 흡수층에 추가로 알코올계, 알데하이드계, 페놀계, 아미드계, 이미다졸계, 아졸계, 할로겐계의 적어도 어느 하나 이상으로 구성된 유기 항균제가 포함된 것에 특징이 있는 항균 부직포 드레싱.
According to claim 1,
An antibacterial nonwoven dressing, characterized in that the absorbent layer further contains an organic antimicrobial agent composed of at least one of alcohol-based, aldehyde-based, phenol-based, amide-based, imidazole-based, azole-based, and halogen-based organic antibacterial agents.
상기 나노섬유는 일반 고분자 수지, 생체적합성 고분자 수지 또는 천연 고분자 수지 중 어느 하나이며,
상기 일반 고분자 수지는 폴리우레탄(Polyurethane(PU)), 폴리비닐클로라이드(Poly(vinyl chloride)(PVC), 아크릴로니트릴부타디엔스티렌공중합체 (acrylonitrile butadiene styrene copolymer(ABS)), 폴리옥시메틸렌(poly Oxy Methylene(POM)), 폴리프로필렌(Polypropylene(PP)), 폴리에틸렌(Polyethylene(PE)),폴리페닐렌옥사이드(Polyphenylene oxide(PPO)), 폴리부틸렌테레프탈레이트(Polybutylene terephthalate(PBT)), 폴리에틸렌테레프탈레이트(Polyethylene terephthalate(PET)), 페놀(Phenol), 불소, 에폭시(Epoxy), 불포화폴리에스터(Unsaturated Polyester(UP)), 폴리메틸메타아크릴레이트(Polymethlymethacrylate(PMMA)), 폴리에테르에테르케톤(Polyetherether ketone(PEEK)), 폴리페닐렌설파이드(Polyphenylene sulfide(PPS)), 폴리아마이드(Polyamide(PA)), 폴리카보네이트(Polycarbonate(PC)) 중 어느 하나이고,
상기 생체적합성 고분자는 프로틴(Protein), 폴리(아스파르트산)(Poly(Aspartic Acid)), 폴리라틱산(Poly(L-Lactic Acid)), 폴리글리콜산(Poly(Glycolic Acid)), PLGA 중 어느 하나이고,
상기 천연 고분자는 셀룰로오스(Cellulose), 콜라겐(Collagen), 젤라틴(Gelatin), 키틴(Chitin), 키토산(Chitosan) 중 어느 하나인 것에 특징이 있는 항균 부직포 드레싱.
According to claim 1,
The nanofiber is any one of a general polymer resin, a biocompatible polymer resin, or a natural polymer resin,
The general polymer resin is polyurethane (Polyurethane (PU)), polyvinyl chloride (PVC), acrylonitrile butadiene styrene copolymer (ABS), polyoxymethylene (poly Oxy) Methylene (POM)), polypropylene (PP), polyethylene (Polyethylene (PE)), polyphenylene oxide (PPO), polybutylene terephthalate (PBT), polyethylene terephthalate Phthalate (Polyethylene terephthalate (PET)), Phenol (Phenol), Fluorine, Epoxy, Unsaturated Polyester (UP), Polymethyl methacrylate (PMMA), Polyetheretherketone (Polyetherether) ketone (PEEK)), polyphenylene sulfide (Polyphenylene sulfide (PPS)), polyamide (Polyamide (PA)), any one of polycarbonate (Polycarbonate (PC)),
The biocompatible polymer is any one of protein (Protein), poly (aspartic acid) (Poly (Aspartic Acid)), poly lactic acid (Poly (L-Lactic Acid)), polyglycolic acid (Poly (Glycolic Acid)), PLGA is one,
The natural polymer is an antibacterial nonwoven dressing, characterized in that any one of cellulose (Cellulose), collagen (Collagen), gelatin (Gelatin), chitin (Chitin), chitosan (Chitosan).
상기 나노층은 초극세 섬유 집합체로 구성된 것으로,
상기 초극세 섬유 사이에 평균직경이 0.1㎛이상 10㎛미만의 소기공과 평균직경이 10㎛이상 50㎛미만의 대기공으로 구성된 것에 특징이 있는 항균 부직포 드레싱.According to claim 1,
The nanolayer is composed of an ultrafine fiber aggregate,
An antibacterial nonwoven dressing, characterized in that it consists of small pores having an average diameter of 0.1 μm or more and less than 10 μm and large pores having an average diameter of 10 μm or more and less than 50 μm between the ultrafine fibers.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190105412A KR102268976B1 (en) | 2019-08-27 | 2019-08-27 | Antibacterial Nonwoven Dressing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190105412A KR102268976B1 (en) | 2019-08-27 | 2019-08-27 | Antibacterial Nonwoven Dressing |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210025401A KR20210025401A (en) | 2021-03-09 |
KR102268976B1 true KR102268976B1 (en) | 2021-06-25 |
Family
ID=75179763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190105412A KR102268976B1 (en) | 2019-08-27 | 2019-08-27 | Antibacterial Nonwoven Dressing |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102268976B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102449750B1 (en) * | 2022-04-21 | 2022-09-29 | 김주영 | Antibacterial sanitary napkin containing platinum nano |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007144149A (en) * | 2005-11-25 | 2007-06-14 | Feng Chia Univ | Antimicrobial composition and wound dressing |
CN103356333A (en) | 2013-07-22 | 2013-10-23 | 科云生医科技股份有限公司 | Wound dressing and preparation method thereof |
KR101833898B1 (en) | 2017-01-19 | 2018-04-13 | 이승희 | Adhesive tape for skin using nanofiber, manufacture apparatus and method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040054331A (en) * | 2002-12-18 | 2004-06-25 | 퍼팩트데이타시스템(주) | Business management system |
KR101810079B1 (en) * | 2015-06-01 | 2017-12-19 | 주식회사 아모그린텍 | Antibacterial dressing |
KR20190023871A (en) * | 2017-08-30 | 2019-03-08 | 주식회사 티앤엘 | Silver Nano Particle-based Wound Dressing Materia |
-
2019
- 2019-08-27 KR KR1020190105412A patent/KR102268976B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007144149A (en) * | 2005-11-25 | 2007-06-14 | Feng Chia Univ | Antimicrobial composition and wound dressing |
CN103356333A (en) | 2013-07-22 | 2013-10-23 | 科云生医科技股份有限公司 | Wound dressing and preparation method thereof |
KR101833898B1 (en) | 2017-01-19 | 2018-04-13 | 이승희 | Adhesive tape for skin using nanofiber, manufacture apparatus and method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20210025401A (en) | 2021-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101150964B1 (en) | Antibacterial wound dressing laminate and method of preparing the same | |
EP1490538B1 (en) | Non-woven fiber assemblies | |
TWI465263B (en) | Medical dressing and negative pressure wound therapy apparatus using the same | |
CN112367950A (en) | Multilayer wound care device with absorption and fluid transfer properties | |
Li et al. | Multiscale composite nanofiber membranes with asymmetric wetability: preparation, characterization, and applications in wound dressings | |
KR101628205B1 (en) | Wound dressing materials having transfer function in one way direction and manufacturing method thereof | |
Sampath Kumar et al. | Electrospun polyurethane and soy protein nanofibres for wound dressing applications | |
KR102268976B1 (en) | Antibacterial Nonwoven Dressing | |
FI123878B (en) | An antimicrobial wound dressing and method for its preparation | |
KR20100133117A (en) | Nanofiber for dressing, dressing composite using the same, and method of manufacturing the same | |
JP5417571B2 (en) | Wound dressing | |
CN101537204A (en) | Medical nanometer antibacterial composite dressing and method for preparing same | |
CN117205354A (en) | Medical adhesive tape with antibacterial and degradation properties and preparation method thereof | |
US20180303763A1 (en) | Dry pad | |
KR20230171242A (en) | Multi-layered wound dressing patch and manufacturing method thereof | |
KR100631108B1 (en) | Wound Dressing | |
KR20200025028A (en) | A method for manufacturing a wound dressing | |
KR20190023871A (en) | Silver Nano Particle-based Wound Dressing Materia | |
KR100667292B1 (en) | Wound dressing | |
KR100896793B1 (en) | Anti-bacterial Shield of a Wound | |
TWI289443B (en) | Nano-silver medical dressing | |
KR20110138988A (en) | Compression bandage consisting of nanofiber web and preparation method thereof | |
CN110623791B (en) | Fiber film layer and band-aid with same | |
KR20120077996A (en) | Wound dressing material and preparation method thereof | |
Mohammadi et al. | Polyurethane/Natural Polymer Blends Nanofibers for Electrospun Wound Dressings Application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right |